NEXALIN TECHNOLOGY INC (NXL) Stock Price, Quote, News and Overview
NASDAQ:NXL - Nasdaq - US65345B2016 - Common Stock - Currency: USD
NXL Quote, Performance and Key Statistics
NASDAQ:NXL (5/19/2025, 8:00:02 PM)
1.27
0 (0%)
The current stock price of NXL is 1.27 USD. In the past month the price decreased by -26.76%. In the past year, price increased by 25.74%.
NXL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.36 | 235.09B | ||
| ISRG | INTUITIVE SURGICAL INC | 73.51 | 201.30B | ||
| BSX | BOSTON SCIENTIFIC CORP | 39.5 | 157.76B | ||
| SYK | STRYKER CORP | 31.5 | 150.65B | ||
| MDT | MEDTRONIC PLC | 16.29 | 111.54B | ||
| BDX | BECTON DICKINSON AND CO | 12.57 | 50.84B | ||
| EW | EDWARDS LIFESCIENCES CORP | 30.02 | 45.88B | ||
| IDXX | IDEXX LABORATORIES INC | 45.76 | 42.28B | ||
| RMD | RESMED INC | 27.9 | 37.15B | ||
| DXCM | DEXCOM INC | 52.7 | 34.10B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.89 | 33.47B | ||
| STE | STERIS PLC | 27.04 | 24.81B |
Related stock screener links
About NXL
Company Profile
Nexalin Technology, Inc. designs and develops neurostimulation products. The company is headquartered in Laguna Niguel, California and currently employs 6 full-time employees. The company went IPO on 2022-09-16. The firm has developed an easy-to-administer medical device (Generation 1 or Gen-1) that utilizes bioelectronic medical technology to treat anxiety, depression and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit a waveform at 4 milliamps during treatment. The company has also designed and developed a new advanced waveform technology to be emitted at 15 milliamps through new and improved medical devices referred to as (Generation 2 or Gen-2) and (Gen-3). Gen-2 is a clinical use device with a modern enclosure to emit the new 15 milliamp advanced waveform. Gen-3 is a new patient headset that will be prescribed by licensed medical professionals in a virtual clinic setting like existing telehealth platforms. Its products are non-invasive and undetectable to the human body.
Company Info
NEXALIN TECHNOLOGY INC
26072 Merit Circle, Suite 106
Laguna Niguel CALIFORNIA US
Employees: 6
Phone: 19492608090
NEXALIN TECHNOLOGY INC / NXL FAQ
What is the stock price of NEXALIN TECHNOLOGY INC today?
The current stock price of NXL is 1.27 USD.
What is the ticker symbol for NEXALIN TECHNOLOGY INC stock?
The exchange symbol of NEXALIN TECHNOLOGY INC is NXL and it is listed on the Nasdaq exchange.
On which exchange is NXL stock listed?
NXL stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for NEXALIN TECHNOLOGY INC stock?
5 analysts have analysed NXL and the average price target is 5.1 USD. This implies a price increase of 301.57% is expected in the next year compared to the current price of 1.27. Check the NEXALIN TECHNOLOGY INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NEXALIN TECHNOLOGY INC worth?
NEXALIN TECHNOLOGY INC (NXL) has a market capitalization of 16.89M USD. This makes NXL a Nano Cap stock.
How many employees does NEXALIN TECHNOLOGY INC have?
NEXALIN TECHNOLOGY INC (NXL) currently has 6 employees.
What are the support and resistance levels for NEXALIN TECHNOLOGY INC (NXL) stock?
NEXALIN TECHNOLOGY INC (NXL) has a support level at 1.26 and a resistance level at 1.28. Check the full technical report for a detailed analysis of NXL support and resistance levels.
Is NEXALIN TECHNOLOGY INC (NXL) expected to grow?
The Revenue of NEXALIN TECHNOLOGY INC (NXL) is expected to grow by 74.42% in the next year. Check the estimates tab for more information on the NXL EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NEXALIN TECHNOLOGY INC (NXL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NXL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NXL, evaluating the profitability, health, valuation and growth aspects
- NEXALIN TECHNOLOGY INC (NXL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NEXALIN TECHNOLOGY INC (NXL) Sales and EPS estimates to see what analysts future expectations are.
- NEXALIN TECHNOLOGY INC (NXL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NEXALIN TECHNOLOGY INC (NXL) Insider and Institutional Ownership to learn about the owners and their transactions.
- NEXALIN TECHNOLOGY INC (NXL) Stock Chart to make your own analysis
- NEXALIN TECHNOLOGY INC (NXL) Latest news and press-releases to stay up to date.
Does NEXALIN TECHNOLOGY INC (NXL) stock pay dividends?
NXL does not pay a dividend.
What is the Price/Earnings (PE) ratio of NEXALIN TECHNOLOGY INC (NXL)?
NEXALIN TECHNOLOGY INC (NXL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.8).
What is the Short Interest ratio of NEXALIN TECHNOLOGY INC (NXL) stock?
The outstanding short interest for NEXALIN TECHNOLOGY INC (NXL) is 1.46% of its float. Check the ownership tab for more information on the NXL short interest.
NXL Technical Analysis
NXL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to NXL. While NXL has a great health rating, there are worries on its profitability.
NXL Financial Highlights
Over the last trailing twelve months NXL reported a non-GAAP Earnings per Share(EPS) of -0.8. The EPS decreased by -29.03% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -180.15% | ||
| ROE | -206.95% | ||
| Debt/Equity | 0 |
NXL Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to NXL. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of 9.84% and a revenue growth 74.42% for NXL